Obstructive sleep apnoea (OSA) is associated with type 2 diabetes mellitus (T2DM). However, mechanisms mediating association between these two conditions remain unclear. This study investigated, whether the OSA-associated changes in adipose tissue lipolysis might contribute to impaired glucose homeostasis in patient with T2DM. Thirty-five matched subjects were recruited into three groups: T2DM + severe OSA (T2DM + OSA, n = 11), T2DM with mild/no OSA (T2DM, n = 10) and healthy controls (n = 14). Subcutaneous abdominal adipose tissue microdialysis assessed spontaneous, epinephrine- and isoprenaline-stimulated lipolysis. Glucose metabolism was assessed by intravenous glucose tolerance test. Spontaneous lipolysis was higher in the T2DM + OSA compared with the T2DM (60.34 ± 23.40 vs. 42.53 ± 10.16 μmol/L, p = 0.013), as well as epinephrine-stimulated lipolysis (236.84 ± 103.90 vs. 167.39 ± 52.17 µmol/L, p < 0.001). Isoprenaline-stimulated lipolysis was unaffected by the presence of OSA (p = 0.750). The α2 anti-lipolytic effect was decreased in T2DM + OSA by 59% and 315% compared with T2DM and controls (p = 0.045 and p = 0.007, respectively). The severity of OSA (AHI) was positively associated with spontaneous (p = 0.037) and epinephrine-stimulated (p = 0.026) lipolysis. The α2-adrenergic anti-lipolytic effect (p = 0.043) decreased with increasing AHI. Spontaneous lipolysis was positively associated with Insulin resistance (r = 0.50, p = 0.002). Epinephrine-stimulated lipolysis was negatively associated with the Disposition index (r = - 0.34, p = 0.048). AHI was positively associated with Insulin resistance (p = 0.017) and negatively with the Disposition index (p = 0.038). Severe OSA in patients with T2DM increased adipose tissue lipolysis, probably due to inhibition of the α2-adrenergic anti-lipolytic effect. We suggest that dysregulated lipolysis might contribute to OSA-associated impairments in insulin secretion and sensitivity.

Centre for Research on Diabetes Metabolism and Nutrition 3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Cardiology University Hospital Královské Vinohrady Prague Czech Republic

Department of Internal Medicine University Hospital Královské Vinohrady Prague Czech Republic

Department of Laboratory Diagnostics University Hospital Královské Vinohrady Prague Czech Republic

Department of Pathophysiology 3rd Faculty of Medicine Charles University Ruska 87 100 00 Prague 10 Czech Republic

Neurology and Sleep Laboratory INSPAMED S R O Prague Czech Republic

Zobrazit více v PubMed

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2017;14:88–98. doi: 10.1038/nrendo.2017.151. PubMed DOI

Briançon-Marjollet A, et al. The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms. Diabetol. Metab. Syndr. 2015;7:25. doi: 10.1186/s13098-015-0018-3. PubMed DOI PMC

Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes. Chest. 2008;133:496–506. doi: 10.1378/chest.07-0828. PubMed DOI

Aurora RN, Punjabi NM. Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association. Lancet Respir. Med. 2013;1:329–338. doi: 10.1016/S2213-2600(13)70039-0. PubMed DOI

Weiszenstein M, Shimoda LA, Koc M, Seda O, Polak J. Inhibition of lipolysis ameliorates diabetic phenotype in a mouse model of obstructive sleep apnea. Am. J. Respir. Cell Mol. Biol. 2016;55:299–307. doi: 10.1165/rcmb.2015-0315OC. PubMed DOI PMC

Neubauer JA. Invited review: physiological and pathophysiological responses to intermittent hypoxia. J. Appl. Physiol. 2001;90:1593–1599. doi: 10.1152/jappl.2001.90.4.1593. PubMed DOI

Steiropoulos P, Papanas N, Bouros D, Maltezos E. Obstructive sleep apnea aggravates glycemic control across the continuum of glucose homeostasis. Am. J. Respir. Crit Care Med. 2010;182:286. doi: 10.1164/ajrccm.182.2.286. PubMed DOI

Pugliese G, et al. Sleep apnea, obesity, and disturbed glucose homeostasis: epidemiologic evidence, biologic insights, and therapeutic strategies. Curr. Obesity Rep. 2020;9:30–38. doi: 10.1007/s13679-020-00369-y. PubMed DOI

Pallayova M, et al. Sleep apnea predicts distinct alterations in glucose homeostasis and biomarkers in obese adults with normal and impaired glucose metabolism. Cardiovasc. Diabetol. 2010;9:83. doi: 10.1186/1475-2840-9-83. PubMed DOI PMC

Polak J, et al. Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure. Sleep. 2013;36(1483–90):1490A–1490B. PubMed PMC

Polotsky VY, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J. Physiol. 2003;552:253–264. doi: 10.1113/jphysiol.2003.048173. PubMed DOI PMC

Iiyori N, et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am. J. Respir. Crit Care Med. 2007;175:851–857. doi: 10.1164/rccm.200610-1527OC. PubMed DOI PMC

Xu J, Long Y-S, Gozal D, Epstein PN. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic. Biol. Med. 2009;46:783–790. doi: 10.1016/j.freeradbiomed.2008.11.026. PubMed DOI

Yokoe T, et al. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic β-cell replication in mice. J. Physiol. 2008;586:899–911. doi: 10.1113/jphysiol.2007.143586. PubMed DOI PMC

Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J. Appl. Physiol. 2009;106:1538–1544. doi: 10.1152/japplphysiol.91523.2008. PubMed DOI PMC

Plihalova A, et al. The effect of hypoxia and re-oxygenation on adipose tissue lipolysis in COPD patients. Eur. Respir. J. 2016;48:1218–1220. doi: 10.1183/13993003.00602-2016. PubMed DOI

Chopra S, et al. Obstructive sleep apnea dynamically increases nocturnal plasma free fatty acids, glucose, and cortisol during sleep. J. Clin. Endocrinol. Metab. 2017;102:3172–3181. doi: 10.1210/jc.2017-00619. PubMed DOI PMC

Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am. J. Physiol. 1999;277:E1130–E1141. doi: 10.1152/ajpcell.1999.277.6.C1130. PubMed DOI

Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes. 2000;49:677–683. doi: 10.2337/diabetes.49.5.677. PubMed DOI

Boden G, Chen X, Capulong E, Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes 1. Diabetes. 2001;50:810–816. doi: 10.2337/diabetes.50.4.810. PubMed DOI

Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375:2267–2277. doi: 10.1016/S0140-6736(10)60408-4. PubMed DOI PMC

Pereira S, et al. FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress. Am. J. Physiol. Endocrinol. Metab. 2014;307:E34–46. doi: 10.1152/ajpendo.00436.2013. PubMed DOI PMC

Cnop M, et al. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 2005;54(Suppl 2):S97–107. doi: 10.2337/diabetes.54.suppl_2.S97. PubMed DOI

Acosta-Montaño P, García-González V. Effects of dietary fatty acids in pancreatic beta cell metabolism, implications in homeostasis. Nutrients. 2018;10:E393. doi: 10.3390/nu10040393. PubMed DOI PMC

Aronsohn RS, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am. J. Respir. Crit. Care Med. 2010;181:507–513. doi: 10.1164/rccm.200909-1423OC. PubMed DOI PMC

Tahrani AA, et al. Obstructive sleep apnea and diabetic neuropathy. Am. J. Respir. Crit. Care Med. 2012;186:434–441. doi: 10.1164/rccm.201112-2135OC. PubMed DOI PMC

Reinke C, Bevans-Fonti S, Drager LF, Shin M-K, Polotsky VY. Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J. Appl. Physiol. 2011;111:881–890. doi: 10.1152/japplphysiol.00492.2011. PubMed DOI PMC

Weiszenstein M, et al. Adipogenesis, lipogenesis and lipolysis is stimulated by mild but not severe hypoxia in 3T3-L1 cells. Biochem. Biophys. Res. Commun. 2016;478:727–732. doi: 10.1016/j.bbrc.2016.08.015. PubMed DOI

Jensen MD. Adipose tissue and fatty acid metabolism in humans. J. R. Soc. Med. 2002;95:3–7. doi: 10.1177/014107680209500102. PubMed DOI PMC

Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 2008;29:2959–2971. doi: 10.1093/eurheartj/ehn387. PubMed DOI

Winkler G, et al. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur. J. Endocrinol. 2003;149:129–135. doi: 10.1530/eje.0.1490129. PubMed DOI

Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes. (Lond.) 2009;33:54–66. doi: 10.1038/ijo.2008.229. PubMed DOI PMC

Musutova M, Weiszenstein M, Koc M, Polak J. Intermittent hypoxia stimulates lipolysis, but inhibits differentiation and de novo lipogenesis in 3T3-L1 cells. Metab. Syndr. Relat. Disord. 2020;18:146–153. doi: 10.1089/met.2019.0112. PubMed DOI

Stefanovski D, Boston RC, Punjabi NM. Sleep-disordered breathing and free fatty acid metabolism. Chest. 2020;158:2155–2164. doi: 10.1016/j.chest.2020.05.600. PubMed DOI PMC

Boden G. Obesity and free fatty acids. Endocrinol. Metab. Clin. North Am. 2008;37:635–646. doi: 10.1016/j.ecl.2008.06.007. PubMed DOI PMC

Jung UJ, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci. 2014;15:6184–6223. doi: 10.3390/ijms15046184. PubMed DOI PMC

Frayn KN, Tan GD, Karpe F. Adipose tissue: a key target for diabetes pathophysiology and treatment? Horm. Metab. Res. 2007;39:739–742. doi: 10.1055/s-2007-990270. PubMed DOI

Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus 1. Trends Endocrinol. Metab. 2000;11:351–356. doi: 10.1016/S1043-2760(00)00323-4. PubMed DOI

Boden G. Effects of free fatty acids (ffa) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp. Clin. Endocrinol. Diabetes. 2003;111:121–124. doi: 10.1055/s-2003-39781. PubMed DOI

Jun JC, et al. Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep. 2011;34:1207–1213. doi: 10.5665/SLEEP.1240. PubMed DOI PMC

Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol. Scand. 2003;177:385–390. doi: 10.1046/j.1365-201X.2003.01091.x. PubMed DOI

Prabhakar NR, Kumar GK. Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia. Respir. Physiol Neurobiol. 2010;174:156–161. doi: 10.1016/j.resp.2010.08.021. PubMed DOI PMC

Spaak J, et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension. 2005;46:1327–1332. doi: 10.1161/01.HYP.0000193497.45200.66. PubMed DOI

Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J. Am. Coll. Cardiol. 2011;57:119–127. doi: 10.1016/j.jacc.2010.08.627. PubMed DOI

Miyoshi H, Perfield JW, Obin MS, Greenberg AS. Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J. Cell Biochem. 2008;105:1430–1436. doi: 10.1002/jcb.21964. PubMed DOI PMC

Pagnon J, et al. Identification and functional characterization of protein kinase A phosphorylation sites in the major lipolytic protein, adipose triglyceride lipase. Endocrinology. 2012;153:4278–4289. doi: 10.1210/en.2012-1127. PubMed DOI

Morigny P, Houssier M, Mouisel E, Langin D. Adipocyte lipolysis and insulin resistance. Biochimie. 2016;125:259–266. doi: 10.1016/j.biochi.2015.10.024. PubMed DOI

Musutova M, et al. The effect of hypoxia and metformin on fatty acid uptake, storage, and oxidation in L6 differentiated myotubes. Front. Endocrinol. (Lausanne) 2018;9:616. doi: 10.3389/fendo.2018.00616. PubMed DOI PMC

Girousse A, et al. Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass. PLoS Biol. 2013;11:e1001485. doi: 10.1371/journal.pbio.1001485. PubMed DOI PMC

Wang N, Khan SA, Prabhakar NR, Nanduri J. Impairment of pancreatic beta-cell function by chronic intermittent hypoxia. Exp. Physiol. 2013;98:1376–1385. doi: 10.1113/expphysiol.2013.072454. PubMed DOI PMC

Weiszenstein M, et al. The effect of pericellular oxygen levels on proteomic profile and lipogenesis in 3T3-L1 differentiated preadipocytes cultured on gas-permeable cultureware. PLoS ONE. 2016;11:e0152382. doi: 10.1371/journal.pone.0152382. PubMed DOI PMC

Bisogni V, Pengo MF, Maiolino G, Rossi GP. The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea. J. Thorac. Dis. 2016;8:243–254. PubMed PMC

Roder F, et al. Interactions of sleep apnea, the autonomic nervous system, and its impact on cardiac arrhythmias. Curr. Sleep Med. Rep. 2018;4:160–169. doi: 10.1007/s40675-018-0117-4. DOI

Thorp AA, Schlaich MP. Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J. Diabetes Res. 2015;2015:341583. doi: 10.1155/2015/341583. PubMed DOI PMC

Stich V, et al. Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men 1. Am. J. Physiol Endocrinol. Metab. 2003;285:E599–E607. doi: 10.1152/ajpendo.00502.2002. PubMed DOI

Collins S. β-adrenoceptor signaling networks in adipocytes for recruiting stored fat and energy expenditure. Front. Endocrinol. (Lausanne) 2011;2:102. doi: 10.3389/fendo.2011.00102. PubMed DOI PMC

Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function 1 41. J. Lipid Res. 1993;34:1057–1091. doi: 10.1016/S0022-2275(20)37695-1. PubMed DOI

Berlan M, Lafontan M. Evidence that epinephrine acts preferentially as an antilipolytic agent in abdominal human subcutaneous fat cells: assessment by analysis of beta and alpha 2 adrenoceptor properties. Eur. J. Clin. Invest. 1985;15:341–348. doi: 10.1111/j.1365-2362.1985.tb00282.x. PubMed DOI

Mahat B, Chassé É, Mauger JF, Imbeault P. Effects of acute hypoxia on human adipose tissue lipoprotein lipase activity and lipolysis. J. Transl. Med. 2016;14:212. doi: 10.1186/s12967-016-0965-y. PubMed DOI PMC

Michailidou Z, et al. Adipocyte pseudohypoxia suppresses lipolysis and facilitates benign adipose tissue expansion. Diabetes. 2015;64:733–745. doi: 10.2337/db14-0233. PubMed DOI PMC

de Glisezinski I, et al. Decrease of subcutaneous adipose tissue lipolysis after exposure to hypoxia during a simulated ascent of Mt everest. Pflügers Arch. Eur. J. Physiol. 1999;439:134–140. doi: 10.1007/s004240051137. PubMed DOI

Nauck MA, Meier JJ. The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions. Lancet Diabetes Endocrinol. 2016;4:525–536. doi: 10.1016/S2213-8587(15)00482-9. PubMed DOI

Löfgren P, et al. Major gender differences in the lipolytic capacity of abdominal subcutaneous fat cells in obesity observed before and after long-term weight reduction. J. Clin. Endocrinol. Metab. 2002;87:764–771. doi: 10.1210/jcem.87.2.8254. PubMed DOI

Quintana-Gallego E, et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir. Med. 2004;98:984–989. doi: 10.1016/j.rmed.2004.03.002. PubMed DOI

Gharib SA, Hayes AL, Rosen MJ, Patel SR. A pathway-based analysis on the effects of obstructive sleep apnea in modulating visceral fat transcriptome. Sleep. 2013;36:23–30. PubMed PMC

Shaw JE, et al. The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes. Am. J. Respir. Crit. Care Med. 2016;194:486–492. doi: 10.1164/rccm.201511-2260OC. PubMed DOI

Martinez-Ceron E, et al. Effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea and type 2 diabetes a randomized clinical trial. Am. J. Respir. Crit. Care Med. 2016;194:476–485. doi: 10.1164/rccm.201510-1942OC. PubMed DOI

Loffler KA, et al. Continuous positive airway pressure treatment, glycemia, and diabetes risk in obstructive sleep apnea and comorbid cardiovascular disease. Diabetes Care. 2020;43:1859–1867. doi: 10.2337/dc19-2006. PubMed DOI

Authors/Task Force Members et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. 2013;34:3035–3087. doi: 10.1093/eurheartj/eht108. PubMed DOI

Boston RC, et al. MINMOD millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol. Ther. 2003;5:1003–1015. doi: 10.1089/152091503322641060. PubMed DOI

Muscle Lipid Oxidation Is Not Affected by Obstructive Sleep Apnea in Diabetes and Healthy Subjects

Hypoxia Induces Saturated Fatty Acids Accumulation and Reduces Unsaturated Fatty Acids Independently of Reverse Tricarboxylic Acid Cycle in L6 Myotubes